How Can Clinical Flow Cytometry Have Better Reproducibility?

Please complete the following survey that will provide Today’s Clinical Lab and BD Biosciences with important information to better understand pain points in clinical flow cytometry. This survey is sponsored by BD Biosciences.

The survey will take approximately 3 minutes.

Question Title

* 1. Please enter your information

First Name

Last Name

Email Address

Country

Zipcode

Question Title

* 2. Which of the following best describes your job title?

Question Title

* 3. What is the biggest challenge to data reproducibility you face when using flow cytometry?

Question Title

* 4. To drive standardization in clinical flow cytometry, what sources of variability are most impactful to address? (Select top 3)

Reagent Stability (ability to maintain MFI over time)

Sample Preparation (variability between technologists)

Sample Preparation (variability between instrumentation)

Instrumentation (variability in results on the same cytometer)

Instrumentation (variability in results between cytometers in the same lab)

Instrumentation (variability in results across multiple sites)

Nothing

We don’t perform flow cytometry

Other (please specify)

Question Title

* 5. Do you/does your laboratory plan to change how you perform flow cytometry testing in terms of reagents, instrumentation, or workflows?

Yes, in the next 3 months

Yes, in the next 6 months

Yes, in the next 12 months

No, we are happy with our current flow set-up

No plans to use flow cytometry

Question Title

* 6. Which of the following applications does your laboratory use flow cytometry for? (Please check all that apply.)

HIV/Immune Monitoring

Leukemia & Lymphoma

Stem Cell Enumeration

Bone Marrow Transplantation

MRD

None

Other (please specify)